Alivus Life Sciences Ltd. Conference Calls and Earnings Call Transcripts

Alivus Life Sciences Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Oct-Dec 2025 Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Alivus Life Sciences Ltd.
24 Jul 2023
903.85
-0.66%
pdf
logo
Alivus Life Sciences Ltd.
21 Jul 2023
903.85
-0.66%
pdf
logo
Alivus Life Sciences Ltd.
02 May 2023
903.85
-0.66%
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, April 28, 2023 for the Fourth quarter and year ended March 31, 2023 is available on the Company's website at: https://www.glenmarklifesciences.com/pdf/Earnings%20Call%20Transcript_28_April_2023.pdf The said transcript is also attached.
pdf
logo
Alivus Life Sciences Ltd.
28 Apr 2023
903.85
-0.66%
pdf
logo
Alivus Life Sciences Ltd.
01 Feb 2023
903.85
-0.66%
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, January 27, 2023 for the Third quarter and Nine Months ended December 31, 2022 is available on the Company's website at: https://www.glenmarklifesciences.com/pdf/Glenmark Life Sciences-Earnings Call Transcript-Jan- 27_2023.pdf The said transcript is also attached.
pdf
logo
Alivus Life Sciences Ltd.
28 Jan 2023
903.85
-0.66%
pdf
logo
Alivus Life Sciences Ltd.
27 Oct 2022
903.85
-0.66%
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, October 21, 2022 for the quarter and half year ended September 30, 2022 is available on the Company's website at: https://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q2%20FY2022-23.pdf The said transcript is also attached.
pdf
logo
Alivus Life Sciences Ltd.
22 Oct 2022
903.85
-0.66%
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q2 FY2022-23 Earnings Call held on 21st October, 2022 on the website of the Company at: https://www.glenmarklifesciences.com/pdf/GLE9320221021143558.mp3 Request you to kindly take the same on record.
pdf
logo
Alivus Life Sciences Ltd.
08 Aug 2022
903.85
-0.66%
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, 5th August, 2022 for the quarter ended June 30, 2022 is available on the Company's website at: https://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q1%20FY2022-23.pdf Request you to kindly take the same on record.
pdf
logo
Alivus Life Sciences Ltd.
05 Aug 2022
903.85
-0.66%
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Audio recording of Q1 FY2022-23 Earnings Call Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q1 FY2022-23 Earnings Call held on 5th August, 2022 on the website of the Company at: https://www.glenmarklifesciences.com/pdf/GLE9320220805142632.mp3
pdf

Earnings Calls Podcast on